Literature DB >> 20822917

Cystic fibrosis and the thoracic surgeon.

Matilde Rolla1, Antonio D'Andrilli, Erino A Rendina, Daniele Diso, Federico Venuta.   

Abstract

Indications for thoracic surgery in patients with cystic fibrosis (CF) are principally represented by pleural diseases including pneumothorax, pleural effusion, and empyema and by parenchymal lung diseases including bronchiectasis, hemoptysis, and pulmonary abscess. Moreover, lung transplantation has proved a viable therapeutic option for progressive respiratory failure due to end-stage CF. Main surgical experiences in this setting are reviewed and discussed.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20822917     DOI: 10.1016/j.ejcts.2010.07.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

Review 2.  Pneumothorax in cystic fibrosis.

Authors:  Ioannis P Kioumis; Konstantinos Zarogoulidis; Haidong Huang; Qiang Li; Georgios Dryllis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Antonis Papaiwannou; Sofia Lampaki; Konstantinos Porpodis; Bojan Zaric; Perin Branislav; Ioannis Mpoukovinas; George Lazaridis; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  Lobectomy in patients with cystic fibrosis.

Authors:  Shahid I Sheikh; Karen S McCoy; Nancy A Ryan-Wenger; Alpa Patel; Stephen Kirkby
Journal:  Can Respir J       Date:  2014-02-12       Impact factor: 2.409

Review 4.  Mycobacterium abscessus Complex Infections in Children: A Review.

Authors:  Arick P Sabin; Patricia Ferrieri; Susan Kline
Journal:  Curr Infect Dis Rep       Date:  2017-10-05       Impact factor: 3.725

Review 5.  Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.

Authors:  Sherstin T Lommatzsch
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

6.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.

Authors:  R Andres Floto; Kenneth N Olivier; Lisa Saiman; Charles L Daley; Jean-Louis Herrmann; Jerry A Nick; Peadar G Noone; Diana Bilton; Paul Corris; Ronald L Gibson; Sarah E Hempstead; Karsten Koetz; Kathryn A Sabadosa; Isabelle Sermet-Gaudelus; Alan R Smyth; Jakko van Ingen; Richard J Wallace; Kevin L Winthrop; Bruce C Marshall; Charles S Haworth
Journal:  Thorax       Date:  2016-01       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.